Company intelligence / Profile preview

Shaanxi TNJONE Pharmaceutical

Xi'an, Shaanxi, China

Ownership: Private
Employees: ~11
Development stage: Other

Overview

TNJONE is a large-scale exporter and supplier of pharmaceutical raw materials, peptides, APIs, veterinary pharmaceuticals, and cosmetic/food/feed additives, supplying both animal and human health industries worldwide. While it does not develop originator drugs or have novel clinical trial assets, it is a key manufacturer for a large portfolio of ingredients—including bulk APIs like semaglutide, liraglutide, tirzepatide, and cosmetic peptides—primarily serving as an ingredient source for other drug/formulation companies.

Therapeutic areas: CardiovascularEndocrinologyInfectious DiseasesMetabolic DisordersDermatologyOncology
Modalities: Small moleculePeptidesRecombinant proteinVitamins
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Shaanxi TNJONE Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shaanxi TNJONE Pharmaceutical.

Explore the full profile